These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
101 related articles for article (PubMed ID: 7029239)
1. Low-dose adriamycin remission maintenance for advanced acute lymphoblastic leukemia: a Southwest Oncology, Group study. Hvizdala E; Komp D; Ragab A; Crist W; Chu JY Med Pediatr Oncol; 1981; 9(5):477-82. PubMed ID: 7029239 [TBL] [Abstract][Full Text] [Related]
2. Adriamycin in combination chemotherapy of adult acute lymphoblastic leukemia: a Southwest Oncology Group study. Shaw MT; Raab SO Med Pediatr Oncol; 1977; 3(3):261-6. PubMed ID: 284167 [TBL] [Abstract][Full Text] [Related]
3. Treatment of adult acute lymphoblastic leukemia with adriamycin, vincristine, and prednisone. Aviles A; Sinco A; Rivera R; Ambriz R; Herrera JG; Pizzuto J Med Pediatr Oncol; 1983; 11(2):141-5. PubMed ID: 6572781 [TBL] [Abstract][Full Text] [Related]
4. Adriamycin in the treatment of childhood acute leukemia. A Southwest Oncology Group study. Ragab AH; Sutow WW; Komp DM; Starling KA; Lyon GM; George S Cancer; 1975 Oct; 36(4):1223-6. PubMed ID: 1058045 [TBL] [Abstract][Full Text] [Related]
5. Reinduction therapy for adult acute leukemia with adriamycin, vincristine, and prednisone: a Southwest Oncology Group study. Elias L; Shaw MT; Raab SO Cancer Treat Rep; 1979 Aug; 63(8):1413-5. PubMed ID: 289442 [TBL] [Abstract][Full Text] [Related]
6. Three dose regimens of adriamycin for induction of remission in acute leukemia in children: a Southwest Oncology Group Study. Starling KA; Berry DH; Britton HA; Humphrey GB; Vats T; Ragab AH Med Pediatr Oncol; 1975; 1(3):271-6. PubMed ID: 1232534 [TBL] [Abstract][Full Text] [Related]
7. Treatment of childhood acute lymphoblastic leukemia with intermediate-dose cytosine arabinoside and adriamycin. Ishii E; Hara T; Ohkubo K; Matsuzaki A; Takeuchi T; Ueda K Med Pediatr Oncol; 1986; 14(2):73-7. PubMed ID: 3458999 [TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone in the treatment of relapsed and refractory acute leukemia. Moore JO; Olsen GA Semin Oncol; 1984 Sep; 11(3 Suppl 1):41-6. PubMed ID: 6385265 [TBL] [Abstract][Full Text] [Related]
9. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group. Nesbit ME; Ertel I; Hammond GD Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373 [TBL] [Abstract][Full Text] [Related]
10. [Clinical experiences with polyethylene glycol-bound E. coli L-asparaginase in patients with multiple recurrences of acute lymphoblastic leukemia]. Jürgens H; Schwamborn D; Körholz D; Wahn V; Göbel U Klin Padiatr; 1988; 200(3):184-9. PubMed ID: 3210651 [TBL] [Abstract][Full Text] [Related]
11. Cyclic combination chemotherapy for acute lymphoblastic leukemia recurring after elective cessation of therapy. Pui CH; Bowman WP; Ochs J; Dodge RK; Rivera GK Med Pediatr Oncol; 1988; 16(1):21-6. PubMed ID: 3422333 [TBL] [Abstract][Full Text] [Related]
12. [Adriamycin and Ara-C infusions in the treatment of refractory leukemia]. Ha K; Yumura K; Doi S; Tawa A; Ikeda T; Yabuuchi H Gan To Kagaku Ryoho; 1982 Mar; 9(3):543-6. PubMed ID: 6964038 [TBL] [Abstract][Full Text] [Related]
13. Adriamycin combined with 10-day Ara-C, vincristine, and prednisone (10-day ADOAP) in the treatment of adult acute leukemia patients under fifty years of age. A Southwest Oncology Group Study. Schreiter SL; Amare M; Stuckey WJ; Oishi N; Saiki JH; Vial R; Pendleton O; Morrison FS Am J Clin Oncol; 1982 Dec; 5(6):641-3. PubMed ID: 7165007 [TBL] [Abstract][Full Text] [Related]
14. Intensive treatment of acute leukemia in adults 70 years of age and older. Walters RS; Kantarjian HM; Keating MJ; Estey EH; McCredie KB; Freireich EJ Cancer; 1987 Jul; 60(2):149-55. PubMed ID: 3474052 [TBL] [Abstract][Full Text] [Related]
15. 4'-(9-Acridinylamino) methanesulfon-m-anisidide (AMSA): a new drug effective in the treatment of adult acute leukemia. Legha SS; Keating MJ; Zander AR; McCredie KB; Bodey GP; Freireich EJ Ann Intern Med; 1980 Jul; 93(1):17-21. PubMed ID: 6930826 [TBL] [Abstract][Full Text] [Related]
16. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas. Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154 [TBL] [Abstract][Full Text] [Related]
18. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. Murphy SB; Bowman WP; Abromowitch M; Mirro J; Ochs J; Rivera G; Pui CH; Fairclough D; Berard CW J Clin Oncol; 1986 Dec; 4(12):1732-9. PubMed ID: 3491184 [TBL] [Abstract][Full Text] [Related]
19. Phase III trial of the Japanese Urological Cancer Research Group for Adriamycin: cyclophosphamide, adriamycin and cisplatinum versus cyclophosphamide, adriamycin and 5-fluorouracil in patients with advanced transitional cell carcinoma of the urinary bladder. Maru A; Akaza H; Isaka S; Koiso K; Kotake T; Machida T; Matsumura Y; Nakagami Y; Niijima T; Obata K Cancer Chemother Pharmacol; 1987; 20 Suppl():S44-8. PubMed ID: 3311445 [TBL] [Abstract][Full Text] [Related]
20. Vindesine, prednisone, and daunomycin in acute lymphoblastic leukemia in relapse. Garay G; Milone J; Dibar E; Pavlovsky S; Kvicala R; Sackmann Muriel F; Montres Varela D; Eppinger-Helft M Cancer Chemother Pharmacol; 1983; 10(3):224-6. PubMed ID: 6345018 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]